Navigation Links
Dr. Ricky Takai, Expert in Designing and Managing Federal Evaluation Studies in Education, Joins Abt Associates
Date:2/3/2009

CAMBRIDGE, Mass., Feb. 3 /PRNewswire/ -- Abt Associates announced that Ricky Takai, Ph.D., has joined the company as Principal Associate. After a brief orientation to the firm, Dr. Takai will become the leader of the company's education work in September 2009. Dr. Takai brings his more than 20 years experience in the design and management of federal evaluation studies in the field of education to the company.

Most recently, Dr. Takai served as Associate Commissioner in the National Center for Education Evaluation and Regional Assistance, Institute of Education Sciences, U.S. Department of Education. In this role he was responsible for national evaluations of major federal education programs including Title I and IDEA. Prior to that, Dr. Takai served as the division director for program evaluation in the Planning and Evaluation Service. He has directed program evaluations in a wide range of education areas such as early reading, educational technology, professional development, math and science education, drug prevention, dropout prevention, high school reform, vocational and adult education, and postsecondary education. In addition, Dr. Takai has served as the Acting Assistant Secretary in the Office of Educational Research and Improvement and the Office of Vocational and Adult Education.

"Ricky's high level work in the field of education research and evaluation, as well as his knowledge of federal education initiatives over the last 20 years, make him a tremendous asset to our company broadly and our growing Education portfolio more specifically," said Kathleen Flanagan, Group Vice President for Domestic Policy at the company.

In 1996 and 2006, Dr. Takai received Presidential Rank Awards. Presidential Rank Awards are reserved for senior career federal employees who have a sustained record of professional, technical, and/or scientific achievement that is recognized throughout the agency and is acknowledged on a national or international level.

Dr. Takai holds a Ph.D. in sociology from Johns Hopkins University and a B.A. from Washington College.

Abt Associates applies scientific research, technical assistance and consulting expertise to a wide range of social, economic and health policy issues; international development; clinical trials and registries; and complex business problems. Founded in 1965, the company provides services to U.S. federal, state and local governments; international organizations and national governments; universities and foundations; media; and major corporations. Its staff of over 1,000 is located in Cambridge, Massachusetts; Atlanta, Georgia; Bethesda, Maryland; Durham, North Carolina; Lexington, Massachusetts (Abt Bio-Pharma Solutions, Inc.); New York, New York (Abt SRBI); and in Africa, Asia, Central Asia, Europe, Latin America, and the Middle East.


'/>"/>
SOURCE Abt Associates
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Celebrity Designer Ty Pennington to Host ADHD Experts on Call Program
3. Valeritas Hires Trade and Distribution Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
4. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine
5. Vicus Therapeutics Chief Executive Officer to Participate in BIOTECH 2007 Expert Panels
6. Valeritas Hires Senior Account Management Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
7. WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
8. Expert Cardiologist Joins Quintiles Medical Group
9. California IVF Experts Tap Ethics Committee for Guidance
10. VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease
11. International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... and CEO, Jim Joyce . In ... Saturday, Bill Gates warned world leaders that ... nuclear weapons. Mr. Gates expressed his concern, which is ... scientific terrorists have access to the necessary tools to ...
(Date:2/24/2017)... KONG, Feb. 24, 2017 China Cord Blood Corporation ... China,s leading provider of cord blood collection, laboratory testing, ... today announced its unaudited financial results for the third ... ended December 31, 2016. Third Quarter of ... third quarter of fiscal 2017 increased by 18.6% to ...
(Date:2/24/2017)... 2017  VWR Corporation (NASDAQ: VWR), the leading global independent ... customers, today reported its financial results for the fourth quarter ... 4Q16 record quarterly net sales of ... organic basis. 4Q16 EMEA-APAC segment ... while the Americas net sales increased 2.5%, or down 0.9% ...
(Date:2/23/2017)... 2017 ... share data, unaudited)Three Months Ended December 31,Twelve Months Ended ... $           ... 89026%Aldurazyme Net Product Revenue 3539(10)%9498(4)%Kuvan ... Product Revenue  756025%297303(2)%Vimizim Net Product ...
Breaking Biology Technology:
(Date:2/3/2017)... ANTONIO , Feb. 3, 2017  Texas Biomedical Research ... Dr. Larry Schlesinger as the Institute,s new ... Texas Biomed effective May 31, 2017. He is currently the ... Director of the Center for Microbial Interface Biology at Ohio ... Schlesinger as the new President and CEO of Texas Biomed," ...
(Date:2/2/2017)... -- EyeLock LLC, a market leader of iris-based identity authentication ... You Should Know About Biometrics in the Cloud ."  ... a growing concern. In traditional schemes, cryptography is used ... schemes such as username/password suffer from inherent weaknesses. ... elegant solution to the problem of high-security user authentication. ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, LLC, ... for the treatment of bacterial infections, today announced ... antibacterial candidates from Pro Bono Bio Ltd (PBB) ... of multi-drug resistant forms of Gram-negative bacteria.   The ... Infectives Ltd, a PBB group company. ...
Breaking Biology News(10 mins):